Login to Your Account

BIO 2013

Price Caps, Other Hazards Face Developing-Region Patent Bids

By Randy Osborne
Staff Writer

Thursday, April 25, 2013
CHICAGO – Navigating the patent landscape in developing countries is hard enough, and made even trickier by such moves as the one made earlier this month by El Salvador, which passed a law that cut prices by at least 30 percent for more than 6,000 medicines, and as much as 60 percent for the most common therapies.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription